ABC transporters CdrLp, Cdr2p and Cdr3p of a human pathogen candida albicans are general phospholipid translocators

Yeast

Volumn 19, Issue 4, 2002, Pages 303-318

  Smriti, ^a   Krishnamurthy, S ^a   Dixit, B L ^b   Gupta, C M ^b   Milewski, S ^a   Prasad, R ^a,c  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

ABC transporters; Candida; CDR1; Membrane asymmetry; Multidrug resistance; Phospholipid translocators

Indexed keywords

ABC TRANSPORTER; BLOCKING AGENT; CARRIER PROTEIN; CYCLOHEXIMIDE; CYTOCHALASIN E; FLUCONAZOLE; FLUORESCENT DYE; MICONAZOLE; N ETHYLMALEIMIDE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PHOSPHOLIPID DERIVATIVE; PYRROLE; ANTIFUNGAL AGENT; CDR1 PROTEIN, CANDIDA ALBICANS; CDR2 PROTEIN, FUNGAL; CDR3 PROTEIN, CANDIDA ALBICANS; FUNGAL PROTEIN; MEMBRANE PROTEIN; PHOSPHOLIPID TRANSFER PROTEIN;

ARTICLE; CANDIDA ALBICANS; CELL MEMBRANE; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFICACY; DRUG SENSITIVITY; ENERGY; FUNGICIDE RESISTANCE; GENE OVEREXPRESSION; GENE TRANSLOCATION; LIPID TRANSPORT; NONHUMAN; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; STRUCTURAL HOMOLOGY; GENETIC TRANSFORMATION; GENETICS; HUMAN; LIPID BILAYER; METABOLISM; PHYSIOLOGY; SACCHAROMYCES CEREVISIAE; TRANSPORT AT THE CELLULAR LEVEL;

CANDIDA; CANDIDA ALBICANS;

ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CANDIDA ALBICANS; CARRIER PROTEINS; CYTOSKELETON; FUNGAL PROTEINS; HUMANS; LIPID BILAYERS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; PHOSPHOLIPID TRANSFER PROTEINS; PHOSPHOLIPIDS; SACCHAROMYCES CEREVISIAE; TRANSFORMATION, GENETIC;

EID: 0037085683     PISSN: 0749503X     EISSN: None     Source Type: Journal    
DOI: 10.1002/yea.818     Document Type: Article

References (57)

1. Dithionite quenching rate measurement of the inside-outside membrane bilayer distribution of 7-nitrobenz-2-oxa-1,3-diazol-4-yl-labelled phospholipids
2. The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter
3. Transbilayer phosphatidylethanolamine movements in the yeast plasma membrane: Evidence for a protein-mediated, energy-dependent mechanism
4. Inventory and function of yeats ABC proteins: About sex, stress, and pleiotropic drug and heavy metal resistance
5. Lipid translocation across the plasma membrane of mammalian cells
6. A novel multidrug efflux transporter gene of the major facilitator superfamily from C. albicans (FLU1) conferring resistance to fluconazole
7. Exposure of phosphatidylserine in the outer leaflet of human red blood cells: Relationship to cell density, cell stage, and clearance by mononuclear cells
8. Changes of the compositional asymmetry of phopholipids associated to the increment in the membrane surface potential
9. Spectroscopic and ionization properties of N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-labelled lipids in model membranes
10. Complete inventory of the yeast ABC proteins
11. Role of translocases in the generation of phosphatidylserine asymmetry
12. Asymmetric distribution of phosphatidylethanolamine in C. albicans: Possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamily
13. Role of the actin cytoskeleton in regulating the outer phosphatidylethanolamine levels in yeast plasma membrane
14. A fourth gene from the Candida albicans CDR family of ABC transporters
15. Evidence for altered ion transport in Saccharomyces cerevisiae overexpressing human MDR1 protein
16. Identification of mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance and its in vitro transcriptional activation
17. Non-mediated flipflop of anionic phospholipids and long-chain amphiphiles in the erthrocyte membrane depends on membrane potential
18. ABC Transporters: From Microorganisms to Man
19. Transbilayer movement of flourescent phospholipids in Bacillus megaterium membrane vesicles
20. Morphological studies of N-acetylglucosamine induced germ tube formation by Candida albicans
21. Chromatographic analysis of lipids
22. Molecular mechanisms of azole resistance in fungi
23. Plasma membrane translocation of fluorescent-labelled phosphatidylethanolamine is controlled by transcription regulators, PDR1 and PDR3
24. Extraction of membrane lipids
25. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: Expression of a yeast multidrug transporter in Baculovirus expression system
26. Characterization of human steroid hormone transport mediated by Cdr1p, multidrug transporter of Candida albicans, belonging to the ATP binding cassette super family
27. Expression of CDR1, a multidrug resistance gene of Candida albicans: In vitro transcriptional activation by heat shock, drugs and human steroid hormones
28. The mutation T315A in Candida albicans sterol 14α-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity
29. Mechanisms of resistance to azole antifungal compounds
30. Rapid transbilayer movement of fluorescent phospholipid analogues in the plasma membrane of endocytosis-deficient yeast cells does not require the DRS2 protein
31. Unusual susceptibility of a multidrug-resistance yeast strain to peptidic antifungals
32. Stress factors acting at the level of plasma membrane induce transcription via the stress response element (STRE) of the yeast Saccharomyces cerevisiae
33. Dipole moment change of NBD group upon excitation studied using solvatochromic and quantum chemical approaches: Implications in membrane research
34. Morphogenesis in Candida albicans
35. Lipid asymmetry in membranes
36. The plasma membrane of Candida albicans: Its relevance to transport phenomenon
37. Molecular cloning and characterization of a novel gene of C. albicans, CDR1, conferring multiple resistance to drugs and antifungals
38. Multiple drug resistance in Candida albicans
39. Multidrug resistance: An emerging threat
40. Drug resistance mechanisms of human pathogenic fungi
41. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene
42. Analysis of the ATP-binding cassette (ABC)-transporter gene of CDR4 from Candida albicans
43. Transbilayer movement of phospholipids in red cell and platelet membranes
44. Loss of Drs2p does not abolish transfer of fluorescence-labelled phospholipids across the plasma membrane of Saccharomyces cerevisiae
45. Membrane fluidity affects functions of Cdr1p, a multidrug ABC transporter of Candida albicans
46. High frequency phenotypic switching in Candida albicans
47. Efg1, an essential regulator of morphogenesis of human pathogen Candida albicans, is a member of conserved class of bHLH regulating the morphogenetic process in fungi
48. Insertion of fluorescent phospholipids into the plasma membrane of a mammalian cell
49. A subfamily of P-type ATPases with aminophospholipid transporting activity
50. Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae
51. MDR1 P-glycoprotein is a lipid translocase of broad specifity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine
52. Does the membrane's physical state control the expression of heat shock and other genes?
53. Continous analysis of the mechanism of activated transbilayer lipid movement in platelets
54. Candida albicans morphogenesis is influenced by estrogen
55. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increased azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus
56. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance
57. 2+-accelerated transbilayer movement of membrane phospholipids